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abstract
Bone tissue is a mineralized structure with a complicated metabolism and due to its mechanical
functions its structure must be adapted to the bone function. The BMP protein group stimulates the
formation of bone and cartilage and influences numerous non-osteogenic processes. As a result of
their osteogenic effect, BMP proteins are used in numerous areas of medicine, including dentistry and
orthopaedics, as well as sport and rehabilitation.

The publications used in this paper were sourced from the PubMed and the Google Scholar databases.
The index entries used to search the databases included BMP, bone morphogenetic proteins, medicine,
dentistry and sport.

BMP proteins have a wide range of applications, particularly in dentistry and sports medicine. The study

demonstrates that autogenous material is the best for bone regeneration as a result of using resources
of BMP proteins and bone-forming cells. Undeniably, the condition of the patient's body undergoing
treatment with BMP is not without significance. According to the authors of the article, all applications
and treatment options with the use of BMPs are yet to be known. Perhaps further development of
medicine will make their discovery possible.
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introduction 

Bone tissue is a mineralized structure with a complicated metabolism and due to its
mechanical functions its structure must be adapted to the bone function. Bone physiology
includes two phases, namely modelling and reconstruction. Modelling is a process that
takes place during bone development. Reconstruction is a process that takes place
throughout the whole life of the body and at the first stage involves osteoclasts resorbing
a mixture of substances in which the main component is collagen type I and hydroxyapatite
[1]. Then the osteoblasts responsible for synthesizing a new matrix, which contains type
I collagen and osteocalcin, matrix proteins (MGP), osteopontins, growth factors, such as
bone morphogenetic (BMP) proteins and the transforming growth factor ß (TGF-ß) [2], are
directed into the resorbed area. In the remodelling process, the balance between functions
of osteoclasts and osteoblasts is important, and in the absence of this balance, bone
diseases occur [3]. The BMP protein group stimulates the formation of bone and cartilage
and influences numerous non-osteogenic processes. These molecules primarily stimulate
the differentiation of mesenchymal stem cells into chondroblasts and osteoblasts [4, 5].
As a result of their osteogenic effect, BMP proteins are used in numerous areas of medicine,
including dentistry and orthopaedics, as well as sport and rehabilitation. In addition to bone
repair, BMPs are involved in cellular and developmental processes, including muscle mass
regulation muscle and bone crosstalk, neurogenesis, as well as inflammation. This family
of proteins may prove useful in designing regenerative therapies in dental surgery and
periodontology. In the near future, these advances are likely to be applied in periodontal
surgery. They may help the approach to the regeneration of entirely lost periodontal
structures [6]. They are used, among others, in the regeneration of periodontium with
bone defects in the furrow [7]. BMPs also prove to be very promising in promoting wound
healing of dental implants [8]. The article presents different types of BMP proteins used
in the treatment of orthopaedic injuries, as well as other clinical areas [9].
The publications used in this paper were sourced from the PubMed and the Google Scholar
databases. We searched for possible applications of BMP proteins in sport, medicine, and
dentistry. The index entries used to search the PubMed and Google Scholar browsers
included BMP, bone morphogenetic proteins, medicine, dentistry and sport.

bone morphogenetic proteins
and growth factors ( gdf )

( bmp )

Bone morphogenetic proteins, BMPs, and the transforming growth factor, TGF-ß, are part
of the superfamily of the transforming growth factor TGF-β. They play a key role in tissue
development, homeostasis of mature tissues and pathogenesis of bone tissue diseases [4,
5]. The TGF-β superfamily may be divided into four subgroups with different mechanisms
of bonding and receptor activation. These subgroups are TGFbs, bone morphogenetic
proteins (BMP) and growth factors as well as growth differentiation factors (GDF), activin/
inhibin and a subgroup composed of factors which do not match the above three [10].
This is the largest subgroup in the TGF-β family. The classes distinguished within its area
are as follows:
- BMP2/4
- BMP 5/6/7/8
- GDF 5/6/7
- BMP 9/10
- GDF 1/3
- BMP3/ GDF10
- GDF8 / GDF11
- BMP15 / GDF9
www.balticsportscience.com
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Fig. 1. Ligand receptor activation TGFb/BMP5 [10]
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BMP-2

This protein was discovered in 1965 by Urist and then in 2007 it was approved as recombinant
human rhBMP-2 in dentistry, where it is used for surgical procedures such as bone grafting
and maxillary sinus surgery [11]. It is a regulator of cartilage and bone structure. It comes
from the superfamily of TNF-Beta [12]. It is composed of 396 amino acids [12], of which they
are signal sequences [13, 14]. It is an acidic glycoprotein in the bone matrix [15]. BMP2
plays a key role in osteogenesis. Its highest expression is in chondrocytes, osteoblasts and
their precursors. It is responsible for the differentiation of mesenchymal stem cells into
chondrocytes. It is also an important factor in the differentiation of osteoclasts (ODF),
promoting osteoclastogenesis in late bone formation [16]. Furthermore, it is essential for
the differentiation of odontoblasts and the formation of vessels in the pulp [17]. In addition,
expression of the BMP-2 gene may be seen in numerous blood vessels and their cells [18].

BMP-4

This protein is encoded in humans by the BMP4 gene, on chromosome 14q22-q23 [19]. The
main role of BMP-4 is to stimulate osteogenesis in the ectopic area, e.g. in subcutaneous
tissue and muscle. It was also shown to be present in tumours (osteomyosarcoma) [20].
It is an important factor in mesodermal differentiation [21]. Together with activin it acts
synergistically to promote early morphogenesis of mandibular and bark molars [22].

BMP-6

It is a protein encoded by the BMP6 gene [23]. Not only does it participate in the induction
of osteogenic differentiation, but also in the body's innate immune response during the
course of inflammatory processes and infections [24]. BMP6 is expressed mainly in
cartilage tissue. It induces differentiation of mesenchymal cells into chondrocytes and
stimulates synthesis of glycoproteins specific to articular cartilage [25]. It is a potent
factor inducing bone growth [26] and an important regulator of the proliferation and
differentiation of bone and cartilage cells [27, 28]. BMP-6 signals through activinlike kinase (ALK) and serine-threonine kinase receptors the phosphorylation of Smad
proteins. BMP-6 may signal through type I Act-RIA, BMP-RIA and BMP-RIB receptors and
type II BMP-RII, Act-RIIA and Act-RIIBi receptors and leads to the phosphorylation of the
Smads receptor (Smad-1, Smad-5 and Smad-8). These receptors then form complexes
with co-Smad (Smad4) and are transported to the cell nucleus, where they exert gene
regulation. For BMP proteins, Smad activation is the main signalling pathway [29]. It
is also known that BMP-6 is involved in embryonic skin development and influences
cytoskeleton organization and collagen expression [30].

BMP-7

This protein participates in many physiological processes of the body, including
embryogenesis, haematopoiesis, neurogenesis, and skeletal morphogenesis. Clinically,
it is used to induce the differentiation of mesenchymal stem cells present in the area of
a bone fracture into chondrocytes, osteoclasts and even form a new bone as a result of
calcium deposition [31].

the application of bmp proteins

As early as 2009, Schuberth and his team showed that BMP proteins are very useful
in patients undergoing foot and ankle surgery, who are at a high risk of bone healing
complications. The results of such analyses showed that bone morphogenetic proteins in
those patients proved to be useful [32].
The proteins BMP2 and BMP7 are particularly important in the treatment of acute and
open shaft fractures of the tibia and facial surgery [33-35]. They have been approved by the
www.balticsportscience.com
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US Food and Drug Administration (FDA). For facial surgery, the FDA-approved INFUSE®
bone grafts, which consist of recombinant human BMP-2 placed on top of absorbable
collagen sponges and are used to induce new bone tissue at the site of implantation [33].
BMP-2 is primarily used for bone regeneration. It has the ability to initiate a cascade of
bone formation including migration of mesenchymal stem cells and their differentiation
into osteoblasts [36]. Additionally, BMP-2 was found to induce ectopic bone formation,
soft tissue hematomas, and bone resorption around implants [35, 37-39].
An alternative may be human bone morphogenetic protein-2 (hBMP-2) used for autologous
bone grafting, which is used in a variety of orthopaedic procedures including spinal fusions,
oral surgery, bone, cartilage, as well as tendon and ligament repair [40].
The BMP7 protein is used in rotor injuries, which usually lead to a prolonged pain and
reduced mobility in the shoulder joint [41]. Gomes et al. [42] discovered that a postoperative
injection of autologous bone marrow (BM) mononuclear cells can increase the functional
status of a patient. This resulted in the opening of normal morphology of the tendon-bone
junction. Finally, KGN successfully improved the quality of tendon healing following rotator
cuff surgery [43]. BMP-7 was also shown to aid the complete integration of a tendon graft
into newly formed trabecular bone during an anterior cruciate ligament reconstruction [44].
BMP-2 proteins are also used in traumatology, sports medicine, sports surgery, and
spine surgery [45]. A disadvantage in using these proteins is their poor solubility at the
physiological pH [33, 46-48], rapid clearance and a relatively short biological half-life
[33, 49].
BMP-7 proteins were used in the reconstruction of the alveolar cleft (Osigraft; Stryker
Biotech, UK) [50]. 9 patients with unilateral jaws and 2 with bilateral cleft jaws were
treated with RhBMP-7 [51]. The mean age of the patients was 10.4 years. Six months after
the procedure, bone formation was observed on radiographs. The effects of BMP-7 on the
course of orthodontic treatment and jaw growth were monitored for the subsequent 10 years.
A follow-up examination was performed every 3 days for the first 10 days, then every week for
3 months, and then after 6 months and after 1 year for 10 years. During each appointment,
bone growth, tooth eruption and the interaction between the mandible and maxilla were
monitored. Patients with unilateral cleft were radiographically assessed for normal bone
formation, against the Kindelan score grades of 1 or 2. In patients with bilateral cleft, the
condition was graded 3 or 4 because of partial or complete bone abnormality. Orthodontic
treatment was started in children who had received a transplant. The growth of the jaw
with the use of BMP appeared to be similar to that with the use of autogenous bone. Longterm complications and abnormalities in bone growth were not detected [50].
A study was performed during which hydroxyapatite with recombinant rhBMP-2 factor
was applied to the extraction sockets in the experimental group in order to preserve the
alveolar process. However, in the control group, beef bone was inserted. The results were
compared for both the histological and clinical bone formation. The height of the alveolar
process in the two groups was similar, although the width was relatively smaller in the
study group than in the control group. The percentage increase was on average from
25.37% to 17.23% in the experimental group and 6.13% to 4.32% in the control group.
The use of rhBMP-2 / HA results in an increased ability to form new bone in the first 3
months compared to the use of bovine bone [52].
In addition, BMP7 is used in the treatment of cardiovascular diseases as an anti-fibrotic,
anti-inflammatory and anti-apoptotic agent [53]. It is a protective factor in diabetic
www.balticsportscience.com
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nephropathy [54, 55] as well as in kidney cells [56]. BMP-7 was found to promote
odontogenic differentiation of pulp-derived stem cells [57].

BMP-4

The BMP4 protein may be used in such fields of medicine as neurology and cardiology.
Amyotrophic lateral sclerosis (ALS) is an adult-onset fatal neurodegenerative syndrome
characterized by a systemic loss of motor neurons with marked astrocytosis and microgliosis
in the spinal cord and the brain. Shijo et al. [58] showed that BMP4, with its downstream
signalling, might be a new therapeutic target for therapies modifying the course of a
disease in ALS [58]. It was also investigated whether spontaneous exercise increases the
risk of progression of pathological cardiac hypertrophy with the involvement of BMP4
proteins. However, given the pro-inflammatory function of BMP4 induced by training, a
reduction in bone BMP4 content may be beneficial for the failing heart, but more research
is needed in order to better understand the relationship between bone metabolism and
heart failure [59].

BMP-6

With the onset of menopause in women, the balance between bone regeneration and
resorption processes is disturbed. They become brittle and prone to break easily. This is
related to a decrease in osteoinduction resulting from a decrease in growth factors, such as
bone morphogenetic proteins in the bone extracellular matrix [60]. Studies were performed
involving systemic administration of recombinant BMP-6 protein to ovariectomised rats.
These studies showed that the BMP-6 protein might be a bone anabolic agent with a
systemic effect that may be used in patients with osteoporosis for bone regeneration [60].
Fractures among the elderly, especially those suffering from osteoporosis, are also a
significant problem for medicine. BMP proteins have a therapeutic potential that enables
a better fracture healing in such patients. Studies on mice were conducted in this regard.
It was proven that the BMP-3 protein is the initiator of bone tissue repair with the highest
intensity occurring 24 hours after the injury. In mice, the BMP-2 protein influenced the
differentiation of mesenchymal stem cells (MSCs) into osteoblasts (together with BMP-6
and BMP-9 they act as the strongest signal for conversion) [61].
In one study BMP proteins were used to treat an open tibial fracture in 450 patients. During
a one-year observation, it was noticed that higher doses of BMP2 effectively improved the
bone healing process compared to patients treated in a standard way [62].
MSC and their transformation into osteoblasts are crucial in the implant treatment, the
use of bone substitute materials and scaffolding for bone cells. What is characteristic
and distinctive of the bone tissue that is formed through regeneration is that it is almost
indistinguishable from the tissue that is undamaged. This differentiates it from soft tissues,
where a scar is formed at the site of damage. BMP proteins, along with other factors,
are involved in recruiting MSCs that multiply, differentiate and lead to bone formation
around the injury by endothelial ossification approximately 7-10 days after the injury. This
is followed by chondrogenesis under the signalling action of BMP, TGF-2 and -3, and in
the next stage cartilage is transformed into the bone tissue [63].

materials for bone regeneration

It is important that the area that undergoes bone regeneration is free from infection,
both in bone tissue and in the surrounding tissues. It should also show an adequate level
of blood supply. The patient's general diseases also reduce the regenerative capacity of
the bones [64].
www.balticsportscience.com
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The materials used for bone regeneration induce the repair process by osteogenesis,
osteoinduction and osteoconduction, and their selection should be adjusted in each case,
e.g. to the size of the bone defect, biomechanical properties, shape and volume. 4 classes
of materials used for supplementing bone defects are as follows:
a. autogenous: the material comes from the same person and is taken from a different
area of the body; freshly harvested tissue contains living cells and osteoinductive
factors, including BMP-2 and -7, FGF, IGF, and PDF. 41 Additional material shows no
immunogenicity and no risk of viral disease transmission [65].
b. allogeneic preparations: the material comes from another person (the material comes
from conspecific), collected from a living donor or corpse. However, this material
displays immunogenic properties a risk of transmitting viral diseases and bacterial
infections [66].
c. xenogeneic: it is derived from other species than humans (pigs, cattle), but carries a
risk of transmitting zoonoses [67].
d. bone substitutes: they are capable of causing cell migration and proliferation, and their
differentiation into cells is necessary for bone regeneration. Natural origin: collagen,
elastin, alginate. Synthetic materials: hydroxyapatite, calcium phosphate cement [68].
Numerous studies have shown that porous silicon (pSi) may be used as a carrier for BMP [6971]. proteins due to its large surface area and porous volume, combined with its biocompatibility
and ability to decompose into non-toxic products under physiological conditions [72, 73]. In
addition, pSi has been found to have beneficial properties in the field of bone regeneration
[74-79], including its ability to induce the growth of hydroxyapatite [80, 81]. pSi has been
found to promote osteoblast adhesion and initiate the maturation process [82].

practical application

The current treatment strategies typically involve the use of autogenous bone grafts
from such places as the fibula, iliac crest and ribs, the retromolar triangle area, the
area between the mandibular foramen and mandible symphysis, tuberosity of maxilla,
post-extraction site area, and outer oblique line. They are collected as non-vascularized
or vascularized grafts. These transplants are characterized by numerous limitations,
including degree of difficulty in performing the operation, risk of failure during surgery,
bone resorption, complications at the site of anastomosis, severe infections and phantom
pain [83, 84]. Therefore, a new, reliable bone regeneration strategy is needed [37].
As mentioned earlier, attention should be paid to proper blood supply to the area around
the injury. Proper oxygen supply is necessary for osteoclasts and osteoblasts. Pressure on
the transplanted material or its lack of stability disrupts its oxygen supply, thus disrupting
regenerative processes. Therefore, it is recommended not to use a full or partial denture
to eliminate pressure and quitting smoking, which reduces blood flow to the transplant
site (vasoconstriction phenomenon) [68].
A) Autogenous grafts – taken from the ilium, tibia, ramus and the symphysis of the
mandible. The disadvantages are two surgical fields (the site of the graft collection and
the area for which the collected material was intended), hematomas, damage to nerve
trunks, blood loss, pain during movements, and cosmetic defects. The material taken from
the mandibular symphysis may cause sensory disturbances in the lower lip and chins.
Fretwurst et al. [85] conducted a study on 32 edentulous patients for whom bone
augmentation was necessary before implantation. The material was collected from the
iliac crest area and transplanted into the maxilla and mandible according to a standardized
protocol. 150 implantations in total were carried out and then followed for an average of
69 months. The success rate was similar: 96% for the maxilla, and 92% for the mandible.
www.balticsportscience.com
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Other studies [86] focused on fibula grafts for mandibular reconstruction. The fibula
is often used for the reconstructive treatment of patients with head and neck tumours.
Over 15 years of observation showed that in patients who had a vascular fibrous graft
used for their implant therapy integration of the implants with the bone was stable. The
tissue was also checked for the histological aspect of the graft and its properly vascular
structure was found.
B) Allogeneic grafts – they contain BMP proteins, which are MSC cell inducers. The
demineralization process, which the material is subjected to, exposes the BMP protein,
and not only does it act on bone cells, but also stimulates angiogenesis. We distinguish
two types of materials:
• mineralized materials which contain mineralized ingredients and collagen,
• demineralized materials which retain the collagen matrix.
It is assumed that the material with dimensions from 100 to 300 mm has the best
osteoconductive potential. An advantage over the previously discussed material is that
it is not necessary to create a second surgical field. Treatment outcomes are similar to
those in autogenous transplants.
Studies by Xavier et al. [87] were conducted using allogeneic (material taken from a
sheep) and an autogenous transplant for the treatment of lesions within the maxillary
sinus. Then, computed tomography was performed after one week, six months and one
year following the transplant. The results were similar.
Other studies [88] were carried out to restore the atrophied maxillary alveolar process
using an allograft. Histological checks were performed after 4 months (progressive
appearance of host cells in the transplant, weak, still developing new blood supply, sparse
osteoclasts), 6 months (the graft is gradually replaced with new bone, although still with
a low cell activity), and 9 months (areas of newly formed bone along with osteocyte gaps
as a result of resorption).
C) Xenografts – low material cost, availability of a large amount of material is one of the
advantages. They are collected mainly from cattle and horses and therefore require strict
sterilization. For their application to be effective, BMP proteins or platelet-rich plasma must
be used, and usually membranes are required to secure their stability. These materials
are free of organic ingredients.
The stability of implants placed in grafts within the maxilla was tested [89]. In patients
requiring mandibular regeneration and implantation, xenogenic and autogenous materials
were used. Implants were introduced after the healing period. Tests were performed on
each of them and no statistically significant differences in both cases were found.
D) Alloplastic materials – often used with allogeneic grafts. Studies comparing the use of
autogenous grafts (taken from the mandible) and alloplastic material (calcium sulphate)
were also conducted on 12 patients undergoing periodontal treatment. The transplanted
sites healed after secondary exposure with good tissue coverage and soft tissue quality.
No statistical difference in regeneration between the materials used was found [90].

conclusions

BMP proteins have a wide range of applications, particularly in dentistry and sports
medicine. They are important for bone regeneration. Their presence in materials used
to stimulate reconstruction processes correlates, along with other factors, with the
www.balticsportscience.com
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degree of their ability to repair bone defects. Hence, it is an opportunity for patients
with developmental disorders, as well as patients after injuries, who do not accept their
appearance. Thanks to bone regeneration resulting from the use of BMP, it is possible to
improve their quality of life, both physically and psychologically.
The study demonstrates that autogenous material is the best for bone regeneration as a
result of using resources of BMP proteins and bone-forming cells. Undeniably, the condition
of the patient's body undergoing treatment with BMP is not without significance.
According to the authors of the article, all applications and treatment options with the
use of BMPs are yet to be known. Perhaps further development of medicine will make
their discovery possible.
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